Interview with Jenny Devenport
Publications are part of the bigger communication plan which also covers PR, scientific dialog, promotion, training, and internal communications. Writing publications should follow an overall strategy for the compound or therapeutic area. They are necessary for further steps like having promotional material, HTA submissions, scientific/medical dialog, etc.
They should not be an afterthought or seen as a pure incentive.
We also discuss the following points:
1. Publication is a critical part of the scientific process,
It is important to communicate the results
Peer review still adds credibility to research
Important for further steps
Need to have transparency – refer to clinical trials .gov
History of not publishing data in the past
2. Helps establish credibility with various stakeholders,
3. Enable scientific discussions in the field,
4. Advance science in that disease and in general
A. Types of publications:
Presentations
Abstracts
Posters (original and encore)
Papers
Methods characterization (to the standard of reproducibility)
Results presented accurately and in a balanced manner
Clinical and statistical conclusions are consistent
Jenny Devenport
Director, Biostatistics at Roche
Agile, results-driven, Biostatistics and Health Outcomes Leader with extensive experience in building/ developing teams, encouraging effective cross-functional collaboration, and championing scientific curiosity to improve patient care through rigorous analysis and effective communication. Adept in devising and delivering change management strategies and organizational training to maintain employee motivation and focus in an evolving marketplace. Proficient at articulating and measuring strategic impact of evidence generation and communication initiatives.
Never miss an episode!
Join thousends of your peers and subscribe to get our latest updates by email!
Get the